Abituzumab in SSc-ILD

Clinical trial NCT02745145 · TERMINATED

Trial details

NCT number: NCT02745145
Sponsor: EMD Serono Research & Development Institute, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Systemic Sclerosis-associated Interstitial Lung Disease

Start date: 2016-05-31
Primary completion: 2018-05-30
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.